Dr. Robert Arthur Chong, MD, PhD

Dr. Chong practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Chong's NPI, 1407202567, was assigned on May 9, 2016. Dr. Chong graduated from Icahn School Of Medicine At Mount Sinai in 2016. Dr. Chong's California license number on file is A155437.

Dr. Chong's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Chong's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Chong is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Neurology. Dmand AI also links Dr. Chong to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chong practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Chong's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Chong is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Chong has a license on file in California.

CMS data shows 103 Medicare services from Dr. Chong across 2 procedure codes in 2024, all of them office visits, for 39 Medicare patients. Medicare paid $11,161 for them.

CMS counts 39 Medicare patients who saw Dr. Chong in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chong's median patient age at 56, with 54% women.

In 2024, Dr. Chong wrote 77 Medicare Part D claims for 20 patients. 87% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $616 in total drug cost. In 2023, CMS named 99 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Chong for performance year 2024, reported as part of a group. Dr. Chong accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chong as offering telehealth.

Dmand AI links 9 papers to Dr. Chong, published from 2014 to 2025. 2014 was the busiest year, with 2. The most frequent topics are Ubiquitination, Amino Acid Sequence and beta Catenin. Dr. Chong has published most often in J Biol Chem. Dr. Chong's most frequent co-authors are Phioanh Nghiemphu, MD, Brian Doyle Brown, MD and Timothy Francis Cloughesy, MD.

CMS Open Payments shows 26 general payments to Dr. Chong from 3 drug and device companies from 2024 to 2025. Compensation for serving as faculty or as a speaker for a medical education program make up the largest share, 73% of the total. Servier Pharmaceuticals LLC paid the most, $23,266. It also lists 2 research payments totaling $1,374 in 2024.

Dr. Chong graduated from Icahn School Of Medicine At Mount Sinai in 2016.

Dr. Chong is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.